Trial Profile
The Efficacy and Safety of Chidamide Combined With VDDT Regimen Vinorelbine Liposomal Doxorubicin Dexamethasone and Thalidomide in Relapse and Refractory Patients With Diffuse Large B Cell Lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Dexamethasone; Doxorubicin; Mitoxantrone; Thalidomide; Vinorelbine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 31 Mar 2020 Planned End Date changed from 1 May 2020 to 1 May 2021.
- 31 Mar 2020 Planned primary completion date changed from 1 May 2019 to 1 May 2020.
- 13 Aug 2018 Planned End Date changed from 1 Dec 2018 to 1 May 2020.